Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06100770Recruiting
Aveir leadless pacemaker study for Medicare patients
This study looks at how well a new type of pacemaker, called Aveir AR, works for people with Medicare. It helps doctors understand if this leadless pacemaker is safe and effective for treating slow heart rhythms.
Sylmar, CaliforniaAges 18 years+ - NCT06101888Recruiting
New Heart Valve for Severe Aortic Leak
This study is testing a new, less invasive heart valve system (TaurusTrio) for people with severe aortic regurgitation (a leaky aortic valve) who cannot have open-heart surgery. It aims to see if the valve is safe and works well to improve symptoms.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06102109Recruiting
Two stitch-free lens fixation methods compared
This study compares two safe, stitch-free surgical methods (Yamane vs. 4-flanged technique) for placing an artificial lens when natural lens support is absent. The goal is to find which approach gives better long-term results.
ViennaAges 18–100 - NCT06102772Recruiting
Combination immunotherapy and targeted therapy for advanced gastric cancer
This trial tests a combination of three drugs—adebrelimab (an immunotherapy), fruquintinib (a targeted therapy to cut off blood supply to the tumor), and a chemotherapy (paclitaxel or albumin-bound paclitaxel)—in people with advanced stomach/gastric cancer whose disease has worsened after one prior chemotherapy. The goal is to see if this new mix can help control the cancer.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06102759Recruiting
Study of adebrelimab and fruquintinib plus chemo for advanced stomach cancer after PD-1 failure
This trial tests a combination of two targeted drugs (adebrelimab and fruquintinib) plus chemotherapy (paclitaxel or albumin-bound paclitaxel) for people with advanced gastric or gastroesophageal junction cancer whose disease progressed after prior PD-1 antibody treatment. The goal is to see if this new combination can help when standard options have stopped working.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06102785Recruiting
Fruquintinib plus TAS102 for advanced stomach cancer
This trial tests a combination of two drugs, fruquintinib and TAS102, for people with advanced stomach cancer that has stopped responding to at least one prior chemotherapy. The goal is to see if this new combination can help shrink tumors or slow the cancer's growth.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06103916Recruiting
Testing the ADNEX model for ovarian tumors
This trial is testing how well a special ultrasound model (ADNEX) can predict whether an ovarian tumor is benign or cancerous. It helps doctors make better decisions, and it’s for people with complex ovarian tumors who speak Dutch.
Veldhoven, North BrabantAges 18 years+ - NCT06104085Recruiting
Imaging test for Trop2 in triple-negative breast cancer
This trial tests a new imaging agent (99mTc-MY6349) to see if it can detect Trop2, a protein found on some breast cancer cells. It may help doctors better see and understand triple-negative breast cancer that has spread.
Beijing, Beijing MunicipalityAges 18–80 - NCT06104280Recruiting
How opioid addiction meds affect sleep and eyes
This study tests how three common medications for opioid use disorder (methadone, buprenorphine, and naltrexone) affect eye function, sleep, and daily body rhythms. It may help find ways to improve treatment for opioid addiction.
Birmingham, AlabamaAges 18–80 - NCT06104241RecruitingEarly Phase 1
Cell therapy for advanced digestive cancers
This trial tests a new cell therapy called BGT007 for people with advanced cancers of the digestive system (esophagus, stomach, pancreas, or colon) that have not responded to standard treatments. The therapy uses your own immune cells, modified to target a protein on your cancer cells.
Xuzhou, JangSuAges 18–70 - NCT06104735Recruiting
Hand training with brain and spinal cord stimulation after spinal cord injury
This study tests whether combining hand exercises with stimulation of the brain and spinal cord can improve hand function after a spinal cord injury. You would attend about 53 study visits at the Bronx VA Medical Center.
The Bronx, New YorkAges 18–85 - NCT06104774Recruiting
Family tai chi after lung surgery for better breathing
This study tests if doing tai chi with your family can help your lungs work better and improve your mood after a thoracoscopic lung surgery. You would practice tai chi exercises and the researchers will check your breathing and mental health.
Taichung, North Dist.Ages 18 years+ - NCT06104852Recruiting
Neurology Research Screening Survey
This trial is a brief survey to see if you might qualify for future neurology research studies. It helps researchers understand your health and find the right study for you.
Boston, MassachusettsAges 18 years+ - NCT06105645Recruiting
Brain wave study for hard-to-treat epilepsy surgery
This study looks at special brain wave patterns called "fast-ripples" to help doctors better plan surgery for epilepsy that doesn't get better with medicine. It may improve how surgeons decide where to operate.
AmiensAges 18–65 - NCT06106191Recruiting
Mindfulness program for chronic low back pain
This trial tests a mindfulness-based program designed to help people with long-term low back pain. It aims to see if combining mindfulness with a personalized approach can improve pain management and daily functioning.
Boston, MassachusettsAges 18 years+ - NCT06106698Recruiting
Washed microbiota transplant for C. diff infection
This trial tests a treatment called washed microbiota transplantation (WMT) for people with a C. diff infection that causes diarrhea. WMT uses processed donor bacteria to help restore healthy gut balance and fight the infection.
Nanjing, JiangsuAges 3–100 - NCT06106516Recruiting
Validating a vital sign monitor device at the hospital
This trial is testing a new device that tracks your vital signs like heart rate and blood pressure while you're in the hospital. It helps make sure the device works correctly so doctors can better monitor your health.
CopenhagenAges Any age - NCT06106529RecruitingPhase 3
Reducing hot flashes in women on hormone therapy for breast cancer
This trial tests a new approach to reduce hot flashes in women taking hormone therapy for breast cancer. You may be able to join if you have at least 14 hot flashes a week and are not taking certain other treatments.
Delft, South HollandAges 18 years+ - NCT06106906RecruitingPhase 1/Phase 2
CD19 CAR-T for Active Lupus
This study tests a new treatment called CD19 CAR-T, which reprograms your own immune cells to attack lupus. It is for people with active lupus that has not responded well to standard therapies.
Wuhan, HubeiAges 18–70 - NCT06106893RecruitingPhase 1/Phase 2
Study of CD19 CAR-γδT cells for active lupus
This trial is testing a new type of immune cell therapy (called CD19 universal CAR-γδT cells) for people with active lupus that hasn't been well controlled by standard treatments. The goal is to see if these specially designed cells can calm the immune system and reduce lupus symptoms.
Wuhan, HubeiAges 18–70 - NCT06107673RecruitingPhase 2
Pill vs chemo before breast cancer surgery
This study compares taking a daily pill (dalpiciclib with hormone therapy) versus standard chemotherapy before breast cancer surgery. It's for postmenopausal women with a common type of early breast cancer that is strongly hormone-receptor positive and HER2-negative.
Shijiazhuang, HebeiAges 18–75 - NCT06107816Recruiting
Fruit and vegetable prescription for diabetes
This trial provides a fruit and vegetable prescription to help people with type 2 diabetes improve their blood sugar control. It is designed for adults who have had diabetes for at least six months, have elevated A1c levels (7% or higher), and meet low-income criteria.
Reading, PennsylvaniaAges 18 years+ - NCT06108830Recruiting
Esketamine and remimazolam for better sleep after surgery
This study tests whether a combination of two medicines (esketamine and remimazolam) can help people sleep better and feel less anxious after surgery. Researchers want to see if this approach works better than standard care.
TianjinAges 20–65 - NCT06110091Recruiting
Improving nighttime urination and sleep in older veterans
This study aims to improve nighttime urination (nocturia) and sleep in adults 60 and older. It offers a program that combines behavioral techniques for both bladder control and insomnia, with weekly visits at an Atlanta VA clinic.
Los Angeles, CaliforniaAges 60 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.